Xywav

Active Ingredient(s): Calcium + Magnesium + Potassium + Sodium Oxybates
FDA Approved: * July 21, 2020
Pharm Company: * JAZZ PHARMS INC
Category: Narcolepsy

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Recent Xywav Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Calcium + Magnesium + Potassium + Sodium Oxybates
  • Solution: 0.234gm/ml + 0.096gm/ml + 0.13gm/ml + 0.04gm/ml, 0.5mg/ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Xywav: (1 result)

Sorted by National Drug Code
  • 68727-150 Xywav Oral Solution by Jazz Pharmaceuticals, Inc.

Drugs with one or more similar ingredients: (211 results)




Note: All times displayed are GMT - 7.

This information has been independently compiled and is for informational purposes only. It is not intended to be a substitute for medical advice from a qualified healthcare professional; nor is it intended to diagnose, treat, cure or prevent any disease. For more details please see the Medical Disclaimer. This page was last updated on 28 September 2020.

We are committed to your privacy.

Copyright © 2005-2020 All Rights Reserved. MedsChat® is a registered trademark of Limelight Innovations L.L.C. 9888 W Belleview Ave #5000, Denver, CO, 80123, USA